Earnest Partners LLC decreased its position in Humana Inc (NYSE:HUM) by 4.5% in the 4th quarter, Holdings Channel reports. The institutional investor owned 126,469 shares of the insurance provider’s stock after selling 5,963 shares during the period. Earnest Partners LLC’s holdings in Humana were worth $31,373,000 as of its most recent SEC filing.
A number of other large investors have also recently bought and sold shares of the business. Cadence Capital Management LLC increased its stake in Humana by 3.6% in the 3rd quarter. Cadence Capital Management LLC now owns 5,887 shares of the insurance provider’s stock valued at $1,434,000 after buying an additional 205 shares during the last quarter. Daiwa SB Investments Ltd. grew its position in shares of Humana by 44.9% during the 4th quarter. Daiwa SB Investments Ltd. now owns 710 shares of the insurance provider’s stock valued at $176,000 after acquiring an additional 220 shares during the period. HL Financial Services LLC grew its position in shares of Humana by 2.1% during the 4th quarter. HL Financial Services LLC now owns 11,205 shares of the insurance provider’s stock valued at $2,780,000 after acquiring an additional 230 shares during the period. Mackenzie Financial Corp grew its position in shares of Humana by 3.6% during the 3rd quarter. Mackenzie Financial Corp now owns 6,642 shares of the insurance provider’s stock valued at $1,618,000 after acquiring an additional 232 shares during the period. Finally, CIBC Asset Management Inc grew its position in shares of Humana by 1.5% during the 4th quarter. CIBC Asset Management Inc now owns 16,996 shares of the insurance provider’s stock valued at $4,216,000 after acquiring an additional 248 shares during the period. Hedge funds and other institutional investors own 97.85% of the company’s stock.
In other Humana news, VP Timothy S. Huval sold 1,382 shares of the stock in a transaction that occurred on Tuesday, December 19th. The shares were sold at an average price of $246.04, for a total value of $340,027.28. Following the sale, the vice president now directly owns 11,557 shares in the company, valued at approximately $2,843,484.28. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is accessible through the SEC website. Also, SVP Brian P. Leclaire sold 1,679 shares of the stock in a transaction that occurred on Thursday, December 21st. The stock was sold at an average price of $245.97, for a total transaction of $412,983.63. Following the completion of the sale, the senior vice president now owns 9,888 shares in the company, valued at $2,432,151.36. The disclosure for this sale can be found here. Over the last ninety days, insiders sold 41,775 shares of company stock valued at $11,169,845. 0.60% of the stock is owned by insiders.
Humana (NYSE:HUM) last released its quarterly earnings data on Wednesday, February 7th. The insurance provider reported $2.06 EPS for the quarter, topping the Thomson Reuters’ consensus estimate of $2.00 by $0.06. The company had revenue of $13.19 billion during the quarter, compared to the consensus estimate of $13.14 billion. Humana had a net margin of 4.55% and a return on equity of 16.13%. Humana’s revenue for the quarter was up 2.4% on a year-over-year basis. During the same period last year, the firm earned $2.34 EPS. analysts predict that Humana Inc will post 13.81 earnings per share for the current year.
Humana announced that its board has initiated a stock buyback program on Thursday, December 14th that permits the company to repurchase $3.00 billion in outstanding shares. This repurchase authorization permits the insurance provider to repurchase shares of its stock through open market purchases. Stock repurchase programs are generally a sign that the company’s board of directors believes its stock is undervalued.
The firm also recently disclosed a quarterly dividend, which will be paid on Friday, April 27th. Investors of record on Friday, March 30th will be issued a $0.50 dividend. The ex-dividend date of this dividend is Wednesday, March 28th. This is an increase from Humana’s previous quarterly dividend of $0.40. This represents a $2.00 annualized dividend and a yield of 0.74%. Humana’s dividend payout ratio (DPR) is 9.59%.
A number of research analysts have recently weighed in on the stock. Zacks Investment Research downgraded shares of Humana from a “buy” rating to a “hold” rating in a research report on Tuesday. Deutsche Bank increased their target price on shares of Humana from $259.00 to $270.00 and gave the company a “hold” rating in a research report on Friday, February 9th. Cantor Fitzgerald reissued a “hold” rating and set a $250.00 target price on shares of Humana in a research report on Wednesday, February 7th. Credit Suisse Group raised shares of Humana from a “neutral” rating to an “outperform” rating and reduced their target price for the company from $264.90 to $246.00 in a research report on Thursday, February 8th. Finally, Goldman Sachs Group assumed coverage on shares of Humana in a research report on Wednesday, January 3rd. They set a “buy” rating and a $305.00 target price for the company. Eight investment analysts have rated the stock with a hold rating and fourteen have assigned a buy rating to the company. Humana has a consensus rating of “Buy” and a consensus price target of $270.47.
COPYRIGHT VIOLATION WARNING: This article was posted by Markets Daily and is owned by of Markets Daily. If you are viewing this article on another website, it was illegally stolen and republished in violation of United States and international copyright & trademark law. The correct version of this article can be read at https://www.themarketsdaily.com/2018/03/14/earnest-partners-llc-has-31-37-million-holdings-in-humana-inc-hum.html.
Humana Inc is a health and well-being company. The Company’s segments include Retail, Group and Specialty, Healthcare Services and Individual Commercial. The Retail segment consists of Medicare benefits, as well as individual commercial fully insured medical and specialty health insurance benefits, including dental, vision, and other supplemental health and financial protection products.
Want to see what other hedge funds are holding HUM? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Humana Inc (NYSE:HUM).
Receive News & Ratings for Humana Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Humana and related companies with MarketBeat.com's FREE daily email newsletter.